Dr Andrew Ahmann is Professor of Medicine and the Director of the Oregon Health and Science University (OHSU) Harold Schnitzer Diabetes Health Center at OHSU. He has been chair of the Oregon Diabetes Guidelines Committee and the Oregon Diabetes Collaborative Program. He volunteers in many capacities for diabetes causes regional and nationally. He served on the ADA Professional Practice Committee. He serves on committees for the Endocrine Society and AACE. He is President of The Portland Area Leadership board of the ADA. He is active in patient care, teaching, and clinical research.

Dr David Ahn is an Endocrinologist with a focus in Diabetes and Metabolism and currently serves as Chief of Diabetes Services at Hoag. He previously was an Assistant Clinical Professor at UCLA. Born and raised in Southern California, Dr Ahn received his Medical Degree and completed a fellowship in Endocrinology at UC San Diego.

He is passionate about empowering people with type 1 diabetes, type 2 diabetes, pre-diabetes and gestational diabetes to optimize their blood sugar control while minimizing the emotional burden of living with chronic disease. He has an interest in diabetes technology, including continuous glucose monitors, insulin pumps and smartphone apps.

Dr Akturk is a board-certified physician in Endocrinology, Diabetes and Metabolism and Internal Medicine. He serves as Communications Director of American Diabetes Association (ADA), Diabetes Technology Interest Group. He received Top Scoring Abstract Honor and one of the Young Investigator Award in 2019 ADA Annual Meeting. He is the founder and program director of Diabetes Dialog, an educational program and diabetes technology workshop for nationwide endocrinology fellows. He has significant amount of publications and he is a reviewer for many leading diabetes journals.

Dr Grazia Aleppo graduated magna cum laude from the University of Catania School of Medicine, Catania, Italy; subesquently completed internship, residency and endocrinology fellowship at the University of Illinois at Chicago.

She is a Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Feinberg School of Medicine, Northwestern University, Chicago. She is also the Associate Chief for Clinical Affairs in the same Division and the Medical Director of the Northwestern Medicine Diabetes Training and Education Program.

Dr Aleppo's clinical interest and research interest is in Diabetes, particularly in the implementation of Diabetes Technology such as Insulin pump therapy and Continuous Glucose Monitoring (CGM) therapy in clinical practice. She has participated in the major clinical trials on the use of CGM in various populations and was the protocol chair for the Replace-BG clinical trial which lead to the approval of CGM therapy for Medicare beneficiaries in the USA.

She has been very active in scholarly activities with over 50 publications and book chapters in peer reviewed journals.

She is the present Chair of the Endocrine Society Clinical Affair Core Committee. Dr Aleppo is also a fellow of the American College of Endocrinology and the American College of Physicians and a member of many professional societies, including the American Diabetes Association, the Endocrine Society, the American Association of Clinical Endocrinologists, and the American College of Physicians.

She serves on the editorial board of BMJ Open Diabetes and Research Care.

Dr Aleppo is considered a prominent national key opinion leader in the field of Diabetes Technology, including insulin pumps, CGM systems and automated insulin delivery.

Dr Argento is a senior clinical endocrinologist at the Maryland Endocrine and Diabetes Center in Columbia, Maryland, where he serves as the Diabetes Technology Director. His practice emphasizes the implementation of advanced diabetes technology to improve the lives of those with insulin requiring diabetes. His experience is enriched by the fact that he has had T1D since 1968, and has personally used CGM since August 2006.

He co-authored multiple chapters in the American Diabetes Association 2013 book, "Putting Your Patients on the Pump," and was primary investigator for 3 published retrospective studies on clinical aspects of CGM use, one of which reported the long term results of personal CGM use in a large group of Medicare aged patients (Endocr Pract. 2014;20:1297-1302), and was first author of a T1D Exchange study on the impact of Medicare pump policies on patient care (J Diab Sci Tech 2020, Vol. 14(2) 257-261). He co-authored a November 2018 Diabetes Care commentary on the use of intermittently scanned CGM, and several other recent commentaries on practical applications of CGM and isCGM. He has presented on CGM and diabetes technology at ADA, EASD, AACE, and Diabetes Technology Society scientific sessions, and spoken to regional, national and international audiences on CGM and insulin pump use. He has represented the Endocrine Society before FDA and CMS on diabetes technology issues, and is actively engaged with and fundraises for JDRF.

Rich is an endocrinologist and Executive Director of the International Diabetes Center at Park Nicollet. In 2010 he was the ADA's, President, Medicine & Science. In 2007, he was ADA's Outstanding Physician Clinician. He serves on the steering committee of the 81 clinic T1D Exchange Clinic Registry.

Dr Bergenstal was Assistant Professor at the University of Chicago, where he received his MD and endocrinology training, before joining the IDC in 1983. He has served as a principal investigator for several NIH grants including, DCCT/EDIC (T1D), ACCORD & GRADE (T2D) and an NIDDK grant evaluating hybrid closed loop technology. Most of his career has focused on the importance of patient-centered team care and glucose pattern recognition with a recent focus on standardizing glucose data reports and using advanced technology to improve diabetes care. He has studied the effective use of insulin therapy from multiple daily injections to pumps and closed loop systems along with the importance of patient support and remote monitoring.

He teaches with the IDC team nationally and internationally on the importance of developing new models of care focused on achieving value in healthcare, defined as reaching the triple aim (high quality and patient experience at a reasonable cost). Dr Bergenstal has been listed in Best Doctors in America since the publication began in 1992, and published over 250 peer reviewed scientific articles.

Cari Berget is a registered nurse and certified diabetes educator with 7 years' experience in pediatric diabetes clinical care and research. She currently manages the pediatric artificial pancreas research team at BDC where the team conducts numerous clinical trials with youth with T1D using emerging diabetes technologies, including closed loop (aka: artificial pancreas) and continuous glucose monitoring technologies. Her research interests include the impact of closed loop technologies on glycemic outcomes and quality of life as well as the translation of closed loop technologies from research settings to the real world.

Julia Blanchette, PhD, is a Nurse Scientist of the Division of Endocrinology and a Diabetes Care and Education Specialist at the University Hospitals Diabetes & Metabolic Care Center. She holds a position at the Case Western Reserve University School of Medicine as an Assistant Professor of Medicine. She completed her Bachelor of Science in Nursing at the Frances Payne Bolton School of Nursing in 2014 and her PhD in Nursing Science in 2019, earning both at Case Western Reserve University. Dr Blanchette was the inaugural Association of Diabetes Care and Education Specialists (ADCES) and the Certification Board for Diabetes Care and Education (CBDCE) Post-doctoral Fellow in Integrated Diabetes Management and trained at the University of Utah College of Nursing. She received the national Rising Diabetes Star Award from ADCES in 2019 and became a fellow of ADCES (FADCES) in 2025. She received the 2024 Behavioral Medicine and Psychology Early Career Award from the American Diabetes Association (ADA) and is on the editorial board for ADA’s interdisciplinary healthcare journal, Diabetes, Obesity and Cardiometabolic CARE.

Dr Blanchette's research focuses on optimizing health equity in diabetes education and care, diabetes self-management barriers (such as financial stress and health insurance), diabetes technology, community-based participatory action research and qualitative analysis methods, and the transition from pediatric to adult diabetes care
diabetes care.

Jen Block, FNP, MSN, BSRN, CDE, has worked in a variety of diabetes care programs over the last 15 years helping people with type 1, type 2 and gestational diabetes. She currently works as a nurse practitioner in the Department of Pediatric Endocrinology at Stanford University. Jen has worked in clinical research on a wide variety of clinical trials of continuous glucose monitors, insulin pump therapy and the artificial pancreas project in both pediatric and adult populations. Jen has published and spoken at a variety of meetings on the integration of technology into diabetes care while maintaining a patient centered model. Her interest in diabetes care, education, research, and technology stems from her own diagnosis of type 1 diabetes.

Dr Bruce Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine.

He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is very active in clinical research on new diabetes products including pharmacological agents to prevent diabetes and control glucose and new insulins and glucose sensors.

He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes. He also sits on the advisory board of many of the leading companies in the field of diabetes care and research including the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps.

He serves on multiple, national collaboratives focused on clinical research and quality improvement for children and adults with type 1 or type 2 diabetes. He has played a central role in the design, implementation and evaluation of the largest U.S.-based diabetes registries, including the Type 1 Diabetes Exchange Clinic Registry and the American College of Cardiology's Diabetes Collaborative Registry. He was integrally involved with the High Value Healthcare Collaborative, an 18-member consortium focused on cost-effective care models for high-cost medical conditions, including diabetes. He previously chaired the American Diabetes Association's Scientific Sessions' Health Care Delivery/Economics Planning Committee.

Shannon Boggs' daughter Raelynn was diagnosed with Type 1 diabetes after going into diabetes ketoacidosis when she was 7 years old. The family was in complete shock. They spent the weekend in the ICU and got a crash course in diabetes management. Leaving the ICU felt like they were bringing a newborn baby home whom they didn't know how to care for. It was quite scary. Shannon has devoted a lot of her time to learning about diabetes management, and continues to learn something new every day. She is very thankful for all the medical advancements in diabetes care. Diabetes management has come very far in the last several decades and it's exciting to see how it continues to progress. As a family, the Boggs' are always looking for ways to make their daughter's life as normal as possible so that diabetes is just a part of her life, and not the main focus. Shannon's goal for her daughter is to teach her she can do anything she wants to in this life, diabetes or not!

Bruce Buckingham, MD, is Professor of Pediatric Endocrinology at Stanford University and Packard Children's Hospital. Dr. Buckingham's research interests have focused on continuous glucose monitoring in children and "closing-the-loop." These efforts are being funded by the Juvenile Diabetes Research Foundation, National Institutes of Health and the Helmsley Foundation and are currently focused on preventing nocturnal hypoglycemia with a predictive low-glucose suspend system, and full overnight closed-loop. Other closed-loop studies are focused on 24/7 closed-loop in the ambulatory setting and assessing ways to improve insulin infusion sets to prolong their wear.

Dr. Caldarella is a graduate of New York University and received his medical degree from SUNY Upstate Medical University. He completed his residency at Brown University in Rhode Island. Dr. Caldarella went on to receive subspecialty training in endocrinology, diabetes and metabolism at the University of Medicine and Dentistry of New Jersey. He is board certified in endocrinology, diabetes and metabolism. He is a Fellow of the American College of Endocrinology and a Fellow of the American College of Physicians. He is also a certified diabetes educator.

Dr. Caldarella was Chair of the New Jersey State Chapter of AACE, one of the most active Chapters in AACE, from 2009 to 2012. He is also Vice-Chair for the Continuing Medical Education Committee.

Shannon Christen is dietician and diabetes expert who works with the Division of Endocrinology, Metabolism & Diabetes, and Cardiac & Vascular Prevention Program within the Division of Cardiology at the University of Colorado Hospital Anschutz Medical Campus. She works closely with lipid specialists to provide nutritional counseling along with new diabetes medication initiation. She is certified in insulin device management such as continuous glucose monitoring systems (CGMS) and trains others interested in this technology. She manages the work flow for approval for all UCHealth Central Endocrinology and Cardiology prescribers for PCSK9 inhibitors, and coordinates care between patient, pharmacy, providers and nursing. Her biggest strength is that she assists providers in decision making of diabetes, cholesterol and weight loss medications to be prescribed based on patient's insurance plans and medical needs.

In 2016 Shannon and her fellow diabetes educators were awarded Partners in Care (nonphysician award) by the University of Colorado Hospital in recognition of the superior care they provide to patients with diabetes.

Claudio Cobelli, PhD, was born in Bressanone (Bolzano) Italy. He is Full Professor of Biomedical Engineering at the University of Padua, Padua, Italy. He is past Chairman of the Graduate Program in Biomedical Engineering (2000-2009) and the PhD Program in Bioengineering (2000-2011) at the University of Padua. His main research activity is modeling, identification and control of physiological systems, especially metabolic systems. His research is supported by NIH, JDRF and the European Community. Dr Cobelli has published 450 papers in internationally peer-reviewed journals, co-authored 8 books and holds 11 patents. He is Associate Editor of the Institute of Electrical and Electronic Engineering (IEEE) Transactions on Biomedical Engineering and Journal of Diabetes Science & Technology. He is on the Editorial Board of Diabetes and Diabetes Technology & Therapeutics. Dr. Cobelli has been Chairman (1999-2004) of Italian Bioengineering Group; Chairman (1990-1996) of IFAC TC on Modeling and Control of Biomedical Systems, and member of the IEEE Award Committee, as well as EMBS AdCom (2008-2009). He has been a member of the Gruppo di Esperti della Valutazione (GEV), Area 09, of the Agenzia Nazionale per la Valutazione del Sistema Universitario e della Ricerca (ANVUR) (2011-2013). Dr Cobelli is currently President of the Organo di Indirizzo of the Azienda Ospedaliera Universita' di Trieste. He is Fellow of IEEE, Biomedical Engineering Society (BMES), American Institute for Medical Biological Engineering (AIMBE) and European Alliance for Medical and Biological Engineering and Science (EAMBES). In 2010 Dr Cobelli received the Diabetes Technology Artificial Pancreas Research Award.

Dr Kenneth Cusi is a Professor of Medicine at the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine at the University of Florida. He received his medical degree in Argentina from the University of Buenos Aires School of Medicine and is board certified in both Internal Medicine and Endocrinology, Diabetes and Metabolism. He completed his residency at the Center of Medical Education and Clinical Research (CEMIC) in Buenos Aires, Argentina, and a clinical fellowship at Baylor College of Medicine in Houston. Prior to joining the University of Florida, Dr Cusi was a faculty for over 15 years at the Diabetes Division, University of Texas Health Science Center at San Antonio (UTHSCSA) and the Veterans Health Administration System in Texas; one of the leading diabetes programs in the country. He is a fellow of the American College of Physicians (ACP) and the American Association of Clinical Endocrinologists (AACE). He has actively participated in many clinical diabetes programs and in the training of many young researchers and clinicians. He is the principal investigator in ongoing NIH grants, investigator-initiated as well as multicenter industry-sponsored studies, with a focus on obesity, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD).

Dr DeSalvo is an Associate Professor of Pediatrics in the Division of Diabetes & Endocrinology at Baylor College of Medicine/Texas Children's Hospital where he serves as Director of Strategic Collaboratives and Type 1 Diabetes Clinic Lead. As a pediatric endocrinologist his greatest passion is helping others live well with diabetes and he considers it a remarkable privilege to shepherd families on their diabetes journey. As a patient-oriented clinical researcher his work focuses on the application of novel technologies for improving diabetes management outcomes and reducing the burden of care for people with diabetes.

He currently serves on the T1D Exchange Quality Improvement Collaborative, Beyond Type 1 Scientific Advisory Council, and College Diabetes Network Clinical Research Advisory Committee. He is a member of the Alpha Omega Alpha Honor Medical Society and Gold Humanism Honor Society.

Daniel Einhorn is Clinical Professor of Medicine at the University of California, San Diego and the Medical Director of the Scripps Whittier Diabetes Institute. He is the Vice-President of the American Association of Clinical Endocrinologists.

Dr Einhorn received his BA from Yale University (Summa Cum Laude, Phi Beta Kappa, Varsity Letter) and his MD from Tufts Medical School (Alpha Omega Alpha). He completed his internship, residency and Fellowship, and then served as an Instructor in Medicine at Beth Israel Hospital, Harvard Medical School. He is a Fellow of the American College of Physicians and the American College of Endocrinology.

Dr Einhorn was Co-Chairman of the American College of Endocrinology Task Force and the Consensus Conference on The Insulin Resistance Syndrome. He is also past Chairman of Clinical Research, past Chairman of Membership, and spent six years on the Board of Directors, American Association of Clinical Endocrinologists (AACE).

He is Co-Editor of Endocrinology and Metabolism Clinics of North America: Type 2 Diabetes and Cardiovascular Disease, and writes a monthly column on diabetes for the popular magazine Diabetes Health. His research and publications cover diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies and pharmaceuticals, combination therapies, and clinical decision-making. He has lectured nationally and internationally on these topics, and has Chaired meetings of the American Federation of Clinical Research in Carmel, The Endocrine Society Clinical Endocrine Update (The Postgraduate Meetings) in Diabetes, symposia of AACE, and over 250 regional symposia.

Sam Ellis, PharmD, BCPS, CDE, is an Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and is a Clinical Pharmacy Specialist with the Barbara Davis Center for Diabetes and the University of Colorado Department of Endocrinology. Much of his research over the past decade has been to establish and evaluate the impact of community pharmacist models in the management of patients with diabetes, including establishing a network of student-managed diabetes intensive rotations, becoming the first school of pharmacy to be a certified diabetes self-management education program and the development of a centralized self-monitoring blood glucose/continuous glucose monitoring (CGM) data interpretation program. Dr Ellis has used his clinical expertise in the area of diabetes to work collaboratively with other investigators to conduct research in the use of continuous glucose monitoring, novel therapeutic approaches to the treatment and prevention of type 1 diabetes and the impact of pharmacy managed CGM programs in oncology, geriatrics and mental health populations.

Andrea Facchinetti, PhD, received a PhD degree in Bioengineering from the University of Padua, Padua, Italy, in 2009. From 2009 to 2014 he was Post-Doctorate Researcher, also at the University of Padua, where he has been serving as Assistant Professor since 2014. His current scientific interests include optimal filtering, Bayesian estimation, deconvolution techniques, neural networks and real-time prediction applied to continuous glucose monitoring (CGM) signals. Dr Facchinetti's major research achievements are the development of the "smart" CGM sensor concept and the embedding of the "smart" CGM algorithms into CGM devices. He is the author of 40 papers published in international peer-reviewed journals, has contributed to over 100 conferences, and holds 7 US and international patents. Dr Facchinetti has been co-investigator of several European and national research projects on the development of new technologies and therapeutic methods in the diabetes field. He is referee for several international peer-reviewed journals, including the Institute of Electrical and Electronic Engineering (IEEE) Transactions on Biomedical Engineering, IEEE Journal of Bio-medical Health and Informatics, Diabetes Care, Diabetes, and Diabetes Technology & Therapeutics. He also served as guest editor for the special issue "Glucose Sensors: Revolution in Diabetes Management" of Sensors journal. Dr Facchinetti's expertise focuses on Signal Processing, Model Identification, Diabetes Technology and Continuous Glucose Monitoring.

Vivian A. Fonseca, MD, FRCP, is the Assistant Dean for Clinical Research at Tulane University School of Medicine in New Orleans, Louisiana. He is also a Professor of Medicine, the Tullis-Tulane Alumni Chair in Diabetes, and Chief of the Section of Endocrinology. He currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the Board of Trustees of the American College of Endocrinology. He is a past President for Science and Medicine of the American Diabetes Association (2012), and has held a leadership role and served on various committees in several other organizations including the American Diabetes Association, the American College of Endocrinology and the American Board of Internal Medicine.

He is Editor-in-Chief of the Journal of Diabetes and its Complications. He was Editor-in-Chief of Diabetes Care from 2007-2011, having formerly been Associate Editor. He was, until 2006, Editor-in-Chief of the Journal of the Metabolic Syndrome and Related Disorders. He served on the editorial board of the Journal of Clinical Endocrinology and Metabolism (2003-2006), and is an ad-hoc reviewer for several other journals, including the New England Journal of Medicine, Lancet, JAMA, Diabetes, etc.

Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London), and the American College of Physicians. Dr Fonseca has served on and been chairman of the Clinical Practice Committee of the American Diabetes Association, the ADA Disaster Task Force, the ADA Strategic Planning Committee and the joint ADA/ACC "Make the Link" Program. He has played a significant role in developing guidelines for treating diabetes (ADA and AACE), managing chronic disease and clinical trials after a natural disaster and in drawing attention to the global epidemic of diabetes, particularly in Asia.

The American Diabetes Association awarded him the ADA Banting Medal for Leadership and Service and the Southern Medical Association awarded him the Seale-Harris Award. He has received several teaching awards and was elected to the Alpha Omega Alpha Honor Medical Society and has been listed among the Best Doctors in the United States, Louisiana and Arkansas.

Dr Fonseca's research interests include Cardiovascular disease in diabetes; finding and comparing treatments for type 2 diabetes; developing and overseeing clinical translational research across disciplines through multiple institutions across the region; assisting scientists with clinical translation of their work. His research interests also include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease, particularly on the role of inflammation and other novel risk factors. He has a research program evaluating inflammation in diabetes, and using technology to improve diabetes care in underprivileged populations. He has been an investigator in several NIH and industry funded clinical trials including the Action to Control Cardiovascular Risk in Diabetes (ACCORD/ACCORDION) study and TINSAL-T2D trial. He is the co-PI of the Louisiana Clinical Data Research Network (LACDRN), funded by PCORI/PCORNET and serves on the PCORNET Clinical Trials Task Force and is an investigator in several current trials including the NIH funded TACT2 trial. He serves on several steering and ancillary study committees and data safety monitoring boards.

Dr. Fonseca has lectured in the United States and abroad. He has published over 300 papers and is the editor of the text book Clinical Diabetes: Translating Research into Practice (El Sevier) and several monographs and book chapters.

Dr Forlenza is an Associate Professor and pediatric endocrinologist at the Barbara Davis Center at the University of Colorado Anschutz Medical Campus as well as a Fellow of the University of Colorado Denver and the University of Minnesota, Minneapolis. He has been caring for children with type 1 diabetes for over 15 years. Dr Forlenza conducts research funded by the National Institutes of Health, the Juvenile Diabetes Research Foundation, the Helmsley Charitable Trust, and the National Science Foundation. His industry research has focused on the pediatric development and approval of the Medtronic 670G, 770G, 780G, Tandem Control-IQ, Insulet Omipod 5, Beta Bionics iLet, Dexcom G6 and G7, Medtronic Guardian 4, and Abbott Freestyle Libre 2. His research is focused on the use of technology to improve the health and lifestyle of people with type 1 diabetes.

Dr Forlenza graduated in 2007 from the University of Florida College of Medicine, where he completed his medical residency in 2010.

Juan Pablo Frías, MD, is Medical Director and Principal Investigator of Velocity Clinical Research in Los Angeles, California. He earned his medical degree from the Vanderbilt University School of Medicine and completed his fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. Dr Frías has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine, where he is currently on the clinical faculty. He has been involved in diabetes and metabolism-related research for over 25 years and has authored numerous peer-reviewed publications in journals including the New England Journal of Medicine, The Lancet, Lancet Diabetes and Endocrinology, Cell Metabolism, Diabetes, and Diabetes Care.

Dr Galindo graduated from the Institute of Medical Sciences at the University of Havana, Cuba. He completed his Internal Medicine residency at the Albert Einstein College of Medicine and an Endocrinology fellowship at North Shore University Hospital in New York. After completing fellowship, he was recruited as an Assistant Professor of Medicine by The Mount Sinai School of Medicine in New York City. In this position, he was appointed Director of the Inpatient Diabetes Service and Medical Chair of the Diabetes Taskforce at Mount Sinai St Luke and West Hospitals. He then joined the faculty of the Division of Endocrinology of Emory University in 2017, to work with his mentor Dr Guillermo Umpierrez, who is an internationally known researcher for his contributions in the area of inpatient diabetes management.

Dr Galindo's research focuses on translational studies and clinical trials in the area of management of diabetes in the hospital and in patients with post-transplantation diabetes (PTDM/NODAT). He currently serves as the chair of the Hospital Diabetes Taskforce of Emory Healthcare System.

He is the recipient of numerous awards from the Endocrine Society, the FLARE award: Future Leaders in Advancing Research in Endocrinology, the American Diabetes Association, the Endocrine Fellows Foundation and the prestigious Leo M. Davidoff Award for outstanding teaching of Einstein's medical students.

His research has been published in leading peer-reviewed journals and presented at the international scientific meetings of the ADA, Endocrine Society and AACE.

Satish K. Garg, MBBS, MD, DM is Professor of Medicine and Pediatrics at the Adult Clinic of the Barbara Davis Center for Diabetes of the University of Colorado School of Medicine in Denver, Colorado. He joined the faculty of the Barbara Davis Center in 1992 and became the founder and director of the Adult Clinic. He established and holds two Garg Endowed Chairs (clinical and clinical research) at the University of Colorado Denver. His team is one of the top teams world-wide in clinical trials involving insulin analogues and novel methods of insulin delivery (pens, pumps, oral, buccal and inhaled) and non-insulin adjunctive treatment options for Type 1 Diabetes. Other areas of interest include: continuous glucose monitors, evaluating the accuracy of meters at high altitude, and artificial pancreas systems.

Dr Garg received a medical degree in medicine at Punjab University in Ludhiana, India, where he also completed a residency in internal medicine at Christian Medical College and Hospital. He completed fellowships in adult endocrinology and diabetes at the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India, and in pediatric endocrinology and diabetes at the University of Colorado at Denver and Health Sciences Center. He is board certified in internal medicine and endocrinology and diabetes.

Dr Garg is the Editor in chief of Diabetes Technology and Therapeutics journal since 2006 and Chair of the planning committee for Clinical Therapeutics and New Technology area for 2007 and 2008 Annual American Diabetes Associations meetings. He is the director of ATDC Diabetes Conference, in Keystone, since 2005. He is a member of the many Endocrine and Diabetes Societies such as: International Diabetes Federation, the American Diabetes Association, the Endocrine Society of India, and the European Association of Study for Diabetes, the Regional Pediatric Endocrine Society of Colorado, the Research Society for Study of Diabetes Mellitus, and numerous other professional societies in both the United States and India. He is an international lecturer and speaker-he received several international oration awards -and has published many chapters in the books, on the editorial boards for many of the diabetes journals globally and has published more than 298 original manuscripts in peer-review journals.

George Grunberger, MD, FACP, FACE is the chairman of Grunberger Diabetes Institute (GDI) in Bloomfield Hills, Michigan. Dr Grunberger, is also Clinical Professor of Internal Medicine and of Molecular Medicine & Genetics at Wayne State University School of Medicine, Professor of Internal Medicine at Oakland University William Beaumont School of Medicine as well as Visiting Professor at First Faculty of Medicine at Charles University in Prague (Czech Republic).

Before establishing GDI in 2002, Dr Grunberger was Director of the Diabetes Program at the Detroit Medical Center for 16 years and the Medical Director of Wayne State University's Morris J. Hood Comprehensive Diabetes Center. Dr Grunberger held tenured Full Professor appointments at the University in Department of Internal Medicine and in the Center for Molecular Medicine and Genetics since 1986. Between 1997 and 2001 he was Henry L. Brasza Director of the Center for Molecular Medicine and Genetics. Prior to that Dr Grunberger served as interim Chairman of the Department of Internal Medicine and Physician-in-Chief of the Detroit Medical Center. Dr Grunberger came to Detroit from the Diabetes Branch (at NIDDK) of the National Institutes of Health in Bethesda, MD. Dr Grunberger received his internal medicine training at Case Western Reserve University in Cleveland, OH, his medical (MD) training at the New York University School of Medicine and his bachelor's degree (in biochemistry) at Columbia College of Columbia University, also in New York City.

Dr Grunberger has published over 150 peer-reviewed manuscripts as well as review articles, abstracts and book chapters. His research interests have spanned the spectrum of subjects related to diabetes and its complications, from basic studies on molecular underpinning of insulin action and insulin resistance to clinical research studies on many aspects of diabetes and its management.

Dr Grunberger has been an active member of many professional organizations where he has held elected positions of leadership. He is currently the Immediate Past President of American Association of Clinical Endocrinologists and Chancellor of the American College of Endocrinology. He is a co-editor of two international diabetes journals. Dr Grunberger has served as an educator of medical students, interns, residents, endocrinology fellows, master and PhD candidates, and junior faculty.

Dr Michael Haller is a Professor and Chief of Pediatric Endocrinology at the University of Florida. As a Gainesville native, and the child of two teachers, he was exposed from an early age to the many incredible educational opportunities afforded by the diverse and highly educated city. His early interests in biology and chemistry combined with his desire to help people and work with children led him pretty directly towards pursuing a career in pediatrics. His interest in pediatric endocrinology was shaped by his grandfather’s experience living with diabetes, experiences volunteering at the Florida Diabetes Camps, and exceptional mentoring from Drs Desmond Schatz, Janet Silverstein and Mark Atkinson.

He has been involved in type 1 diabetes research since the early 1990s and has published over 200 manuscripts and more than 20 reviews/book chapters on type 1 diabetes pathogenesis, prevention, and interdiction. He is the principal investigator or co-investigator on numerous JDRF, NIH, and Helmsley trust funded studies. His goal is to work every day to improve the lives of children and families affected by type 1 diabetes. He’s hopeful that during his career, therapies will be developed that can meaningfully prevent and reverse type 1 diabetes.

Dr Haller's research focuses on predicting, preventing, and ultimately reversing type 1 diabetes through his participation in numerous clinical trials utilizing immunotherapies. Dr Haller serves as the Principal Investigator for the University of Florida TrialNet Clinical Center, Chair of the TEDDY Clinical Implementation Committee, and PI of the UF/Stanford ECHO Collaborative. Dr Haller also leads and participates in technology studies seeking to improve the lives of people living with diabetes through the use of pumps, continuous glucose monitors, and systems that automate insulin delivery.

In his free time, he enjoys spending time with his wife, Dr Allison Haller their 2 children, and their dogs. He also loves to spend time in nature, attend live music, Gator sporting events, and fly planes.

I am a clinical research coordinator and have been living with type 1 diabetes for over 30 years. As an active participant in the DIY diabetes technology space, it's been amazing to see and experience how technology increases quality of life for people living with diabetes and their families, especially over the last few years. DiabetesWise.org aims to meet you where you're at on your diabetes journey and I'm glad to be a part of it.

Christina Hanson is a certified family nurse practitioner and has been working at South Denver Gastroenterology in Denver Colorado for nearly 18 years as an advanced practice provider. She received her Bachelors of Science in Nursing at Bethel University in St. Paul, MN. In 2005, she returned to school and obtained her MSN after completing the Family Nurse Practitioner program at Regis University. Christina is a course director and board of trustee for GHAPP and an active researcher with extensive leadership and teaching experience. She is a champion of evidence-based practice, data-driven care delivery, interdisciplinary collaboration, and quality patient care. Christina is committed to amplifying professional development, growth, and contributions of advanced practice. When not working, she enjoys playing in the great outdoors of Colorado with her husband and two beautiful daughters.

Dr Harari graduated from the Uniformed Services University of the Health Sciences in Bethesda, MD in 1990. He did his Internal Medicine residency at Naval Medical Center, Oakland and completed his Endocrinology and Metabolism Fellowship at the National Naval Medical Center in Bethesda, MD, in 2000. After a 21-year career in the US Navy, he has joined Endocrinology Associates. He is a fellow of the American College of Physicians and the American College of Endocrinology. He has Special interest in Thyroid disease, adrenal disease, and diabetes.

Irl B. Hirsch, MD, MACP, is professor and Diabetes Treatment and Teaching Chair at the University of Washington Medicine Diabetes Institute in Seattle.

Dr Hirsch received his medical degree from the University of Missouri School of Medicine in 1984. He completed residency training in internal medicine at Mount Sinai Medical Center in Miami and Miami Beach, Florida. Dr Hirsch also was fellowship-trained in endocrinology and metabolism at Washington University School of Medicine in St. Louis.

Dr Hirsch has dedicated his career to patient care, clinical research and teaching. His focus in these areas is the treatment and management of diabetes. He has an interest in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. This interest centers on the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improved outcomes for patients.

He has been involved in numerous major clinical research trials, including the DCCT, ACCORD, STAR-1, JDRF Sensor Trial, SEARCH, ORIGIN, ADAG, FLAT-SUGAR, and many more involved with insulin therapy.

Additionally, he has an interest in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control and how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications.

Dr Hirsch has authored more than 300 research papers, including a review of insulin in the New England Journal of Medicine. He also has written more than 60 editorials, three commentaries for The Journal of the American Medical Association, numerous book chapters and four books for patients and physicians.

He is also a much in demand national and international speaker.
He is the past editor-in-chief of DOC News and Clinical Diabetes and former chair of the Professional Practice Committee for the American Diabetes Association and served as a member of the Endocrine Section of the American Board of Internal Medicine. Currently, he is section editor for Up-To-Date.

Dr Hirsch has been honored at every level of his career, including being recognized with the Outstanding Young Physician Award by the University of Missouri Alumni Association in 2001, and in 2003 being honored as the American Diabetes Association's Physician- Clinician of the Year. In 2005, he received the American Association of Clinical Endocrinologists' Distinguished Endocrinologist Award, and in 2013, he received the American Diabetes Association's Josiah K. Lilly Sr. Distinguished Service Award. In April 2022 he American College of Physicians awarded Dr. Hirsch the Samuel Eichold II Memorial Award for contributions in diabetes.

Dr Hood directs NIH- and foundation-funded clinical research aimed at promoting health and quality of life outcomes for people with diabetes. He has expertise and experience with diabetes epidemiology and interventions, study design, methodology, data management, and advanced statistical methods. There are two content threads to his work: 1) construct prevention and treatment programs to address modifiable psychological and family factors that create barriers to optimal diabetes management, and 2) optimize the use of devices and technologies to improve health outcomes. With regard to the first thread, Dr Hood has successfully implemented depression screening programs in tertiary diabetes and GI clinics within a Quality Improvement framework, and recently completed a large-scale clinical trial on a distress prevention program for teens with type 1 diabetes. Dr Hood manages and analyzes all the data from these studies. From a device and technology standpoint, Dr Hood coordinates the Human Factors assessments in Drs Maahs' and Buckingham's closed loop studies and is recognized as one of the experts in this area nationally and internationally. In addition, he has implemented Human Factors assessments in national (e.g., T1D Exchange) studies and registries and is the lead psychologist on 2 of the 4 UC4 grants from NIDDK (Hovorka, PI; Bergenstal, PI). These assessments focus on uptake of devices and technologies, and determining strategies to promote uptake and optimize their use. Dr Hood and his research team have published over 100 scientific articles on these topics and are active presenters at diabetes, behavioral medicine, and advocacy conferences.

Dr Hood also works in clinical and service settings. Dr Hood is a licensed clinical psychologist and is part of the diabetes care team at Stanford. He is the past chair of the American Diabetes Association's Behavioral Medicine and Psychology Interest Group and is currently a member of the Research Policy Committee. He was also a member of the ADA's Call to Congress in March 2017. Dr Hood is an Associate Editor for both Diabetes Care and Pediatric Diabetes.

Scott D. Isaacs, MD, is a board-certified endocrinologist, obesity medicine specialist and medical director at Atlanta Endocrine Associates. Since 1998, Dr Isaacs has focused his medical practice on endocrinology and medical weight loss.

He's treated thousands of patients successfully and helped them lose weight at his practice in Atlanta, Georgia. His expertise and unique hormone-focused approaches to weight loss make Dr Isaacs a valuable source of cutting-edge information and insight.

Dr Isaacs attended medical school at Emory University School of Medicine and continued for residency and fellowship in Endocrinology, Lipids, Diabetes, and Metabolism. He currently serves as a clinical faculty member at Emory University School of Medicine.

Dr Isaacs has published research on diabetes, thyroid disorders, and obesity in numerous peer-reviewed medical journals. A frequent speaker for national and international groups, he's a Diplomate of the American College of Physicians and American Board of Obesity Medicine, as well as a fellow of the American College of Physicians and the American College of Endocrinology. Dr Isaacs is a past president of the Georgia Chapter of the American Association of Clinical Endocrinologists (AACE) and currently serves AACE on a national level. He's also a past president of the Atlanta Chapter of the American Diabetes Association. Endorsed by Jillian Michaels, a consultant for ABC television networks and featured in Health Magazine, Dr Isaacs and his practice are nationally renowned. U.S. News & World Report ranked the Health Management Resources Program, which Atlanta Endocrine Associates licenses, as the No.1 Best Fast Weight-Loss Diet. Additionally, Dr Isaacs regularly serves as an expert contributor for CNN, NPR, as well as national magazines, newspapers, websites, and television shows.

Dr Isaacs is the author of several best-selling books on hormones and weight loss, including: Hormonal Balance: How to Lose Weight by Understanding Your Hormones and Metabolism; The Leptin Boost Diet; Beat Overeating Now! Take Control of Your Hunger Hormones to Lose Weight Fast; Overcoming Metabolic Syndrome; A Simple Guide to Thyroid Disorders: From Diagnosis to Treatment.

In his free time, Dr Isaacs enjoys taking spin classes, hiking, biking, and learning Spanish. He lives with his wife and daughter in Atlanta.

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an Endocrinology Clinical Pharmacy Specialist. She serves as the Co-Director of Endocrine Disorders in Pregnancy and the Director of Education and Training in Diabetes Technology at the Cleveland Clinic Endocrinology and Metabolism Institute. Dr Isaacs earned her bachelor's degree in chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville (SIUE) and completed a pharmacy practice residency at the Philadelphia Veterans Affairs. Dr Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. She served on the American Diabetes Association (ADA) Professional Practice Committee from 2020-2023, the committee that updates the ADA Standards of Care. She is a National Board Member of the Association of Diabetes Care and Education Specialists (ADCES). She co-hosts a podcast titled "Diabetes Dialogue: Technology, Therapeutics and Real-World Perspectives". She was the ADCES Diabetes Care and Education Specialist of the Year in 2020 and inducted into the SIUE Hall of Fame in 2022 for her far reaching contributions in diabetes care.

Dr Boris P Kovatchev is Professor at the University of Virginia (UVA) School of Medicine, Adjunct Professor at UVA's School of Engineering and Applied Science, and the founding Director of the UVA Center for Diabetes Technology. He received his PhD in Mathematics from Sofia University "St. Kliment Ohridski," Bulgaria in 1989. Dr Kovatchev has a 25-year track record in mathematical modeling and computing, with primary focus on diabetes technology since 1996. Currently, he is Principal Investigator of several projects dedicated to the development and clinical testing of closed-loop control and advisory systems for diabetes, including the large-scale NIH/NIDDK International Diabetes Closed-Loop Trial (grant UC4 DK 108483), the Diabetes Impact project DP3 DK 101055 "Network Control of Diabetes: Aligning Artificial Pancreas Design with Physiology," and NIH Project "Nightlight" (grant RO1 DK 085623). His JDRF projects resulted in the [only] computer simulator of the human metabolic system accepted by FDA as a substitute to animal trials for the pre-clinical testing of insulin treatments for diabetes and in the design of the first mobile artificial pancreas system. Dr Kovatchev is author of over 160 peer-reviewed publications, holds 42 U.S. and international patents, and has numerous pending patent applications. In 2008 he received the U.S. Diabetes Technology Leadership Award; in 2011 he was named the UVA's Edlich Henderson Inventor of the Year, and in 2013 he was the recipient of JDRF's Gerold and Kayla Grodsky Award presented for outstanding scientific contributions to diabetes research.

Expertise: Mathematical Modeling, Diabetes Technology, Continuous Glucose Monitoring, Closed-Loop Control and Artificial Pancreas.

Davida F. Kruger, MSN, APN-BC, BC-ADM, has been a certified nurse practitioner in diabetes for more than 40 years at Henry Ford Health System in Detroit, Michigan. Her role includes both clinical practice and research. She is board certified by the American Nurses Association Credentialing Center in Primary Care and by the American Association of Diabetes Educators in Advanced Diabetes Management. She is past Chair of the American Diabetes Association's Research Foundation and has served on the American Diabetes Association's Research Policy Committee. She is also a Past President, Health Care and Education of the American Diabetes Association. She served as Editor of both Diabetes Spectrum and Clinical Diabetes. Ms Kruger has been a principal investigator on numerous research projects and has written widely on diabetes care, authoring the book The Diabetes Travel Guide 2nd edition (2006). Her awards include the Florence Nightingale award for excellence in research, ADA's Rachmeil Levine Award for Distinguished Service, ADA's Award for Outstanding Service in Diabetes Research Funding, The ADA Wendell May's Award, Wayne State University School of Nursing 2014 Alumna of the year and Henry Ford Health System Nursing Excellence Clara Ford Pillar award in Research and Education 2014.

Dr Yogish C. Kudva is an endocrinologist in Rochester, Minnesota and is affiliated with Mayo Clinic-Rochester. He received his medical degree from St. John's Medical College and has been in practice for more than 20 years. Dr Kudva has expertise in treating chronic diabetes, among other conditions.

Dr Kudva has played a key role in the development of the Diabetes Technology Clinic and program, started in 2003 at Mayo Clinic's campus in Rochester, Minnesota. The infrastructure set up by this program resulted in NIH funding for further research in the field of closed-loop (artificial pancreas) therapy for type 1 diabetes in 2009. Since then, he has been involved in research to develop closed loop therapy for diabetes. He has been involved in several pivotal studies of closed loop therapy in the last 7 years

Dr Kudva works closely with Mayo's kidney and pancreas transplant surgical teams to continually improve outcomes of these types of transplant. The transplant program provides long-term insulin independence for more than 60 percent of patients and freedom from hypoglycemia and ketoacidosis for more than 80 percent of patients.

Dr Marcelo Kugelmas received his medical degree with honors from the University of Buenos Aires. After completing his internship and internal medicine residency at University of Southern California-Los Angeles County Hospital in Los Angeles, he moved to Cleveland where he completed his gastroenterology fellowship at the Cleveland Clinic Foundation, and served as Chief Fellow in 1994 -1995. He then moved to Lexington, Kentucky where he pursued further training in hepatology, liver transplantation and advanced endoscopy. Dr Kugelmas remained there until 2000 as an assistant professor. He then moved to Colorado, where he joined the University of Colorado Liver section.

Over the last 20 years Dr Kugelmas' main focus has been on the care of patients with liver diseases. He became an associate professor of medicine in 2004, before joining South Denver Gastroenterology. Dr Kugelmas is a national lecturer on topics of chronic liver disease, has presented regularly at multiple gastroenterology, liver and transplantation annual meetings, and has published more than 40 papers in peer-reviewed journals.

Dr Edward La Cava is a highly regarded endocrinologist formerly on medical school faculties at the University of Southern California and University of Washington, as well as former Chair of Medicine and Section Chief, Division of Endocrinology at EvergreenHealthcare in Kirkland, WA. Previously he served for several years as Senior Editor for the American Diabetes Association's Diabetes Forecast Magazine as well as on the Pacific Northwest ADA Board of Directors. Dr La Cava is a Fellow of the American College of Endocrinology and has been a guest lecturer regionally, nationally and internationally on all aspects of diabetes, diabetes technology and endocrinology. He has authored numerous articles and textbook chapters on diabetes care and its complications.

Dr Lori Laffel is Chief of the Pediatric, Adolescent & Young Adult Section; Senior Investigator/Head of Section on Clinical, Behavioral & Outcomes Research; and Professor of Pediatrics at Joslin Diabetes Center, Harvard Medical School. As a pediatric endocrinologist/clinical investigator, she has published over 400 articles. She has been on Advisory Board of ISPAD and a member of Clinical and Research Advisory Committees for Breakthrough T1D (formerly JDRF).

Dr Laffel works with the ADA, as member of Boston Leadership Board, past member of National Board of Directors, Committee for Professional Practice Guidelines, co-chair of Working Group on Transition, and past chair of ADA’s Youth Strategies Committee. She is a member of ADA’s Pathway Mentor Advisory Program. Her research aims to understand and overcome challenges to diabetes self-care leveraging diabetes technologies to improve glycemic and psychosocial outcomes. She has been funded by NIH and foundations. She received ADA’s 2015 Outstanding Physician-Clinician Award, Greater Boston Chamber of Commerce 2016 Pinnacle Award, and 2016 University of Miami School of Medicine Hall-of-Fame Award.

Dr David Lam graduated from The University of Maryland School of Medicine in Baltimore, Maryland. Following medical school, he completed his residency training in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania and then moved to New York City, where he completed his clinical fellowship training in Endocrinology, Diabetes, and Bone Diseases at Mount Sinai.

During his fellowship training he developed areas of interest in improving the treatment of the diabetic emergency, diabetic ketoacidosis (DKA), and the metabolic changes associated with obesity before and after bariatric surgery. With funding support from the Department of Medicine Advancing Clinical Excellence in Medicine training grant, he was the principal investigator in developing a multi-disciplinary DKA care pathway for patients admitted to Mount Sinai.

As a faculty member, Dr Lam has devoted his efforts towards clinical care, quality improvement projects for patients with diabetes in the hospital, as well as participating in clinical trials for patients with type 1 diabetes.

Carol J. Levy, MD, CDCES is a Professor in the Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, and in the Department of Obstetrics, Gynecology and Reproductive Science.  She is a board-certified Endocrinologist and Certified Diabetes Educator.  Dr Levy is also the Director of the Mount Sinai Diabetes Center and Type 1 Diabetes Clinical Research.  She is an expert in type 1 diabetes and diabetes in pregnancy as well as general endocrinology.  She has over 20 years' experience managing patients with these conditions.

Dr Levy attended medical school with the goal of becoming a physician that she would want to see as a patient.  She believes that Endocrinology is an area where physicians help guide patients on the right path to improve health but the 'ball' is really in the patient's court.  For Dr Levy, the role of the physician to educate and support the patient is of key importance.  During her training at Joslin Clinic, she developed an interest in taking care of pregnant women with diabetes and delighted in the challenge of caring for '2' patients.  She finds general endocrinology both exciting and fascinating as well.  Explaining the reason the thyroid works the way it does, hormonal fluctuations and the impact of this on an individual, and the reasons at times the pancreas (the gland that normally makes insulin) does not, is critical to help people take care of their illnesses.  As a child, she was diagnosed with type 1 diabetes and the patience and respect she received from clinicians along the way (including her obstetrician for her own pregnancies) reinforced her belief that a patient who understands the purpose of a treatment is one who is able to best able to manage his/her disease.

As the Director of the Artificial Pancreas Research Program, she and her team strive to continue to improve the lives and glucose control of people with diabetes by forwarding this technology through both research and clinical care.  This pioneering clinical research program collaborates with multiple researchers both nationally and internationally and has the potential to revolutionize the management of patients with type 1 diabetes.

Dr Vinni Makin is the Director of Endocrinology for the Cleveland Clinic's Endocrinology and Metabolism Institute in the East region; where she provides overall direction and leadership for endocrinology operations for six distinct facilities. With a career spanning the areas of education, clinical work and administration, Dr Makin is renowned for her expertise at balancing the theoretical knowledge of endocrinology with actual clinical practice. She has successfully devised scalable processes for making healthcare delivery more efficient, while continually improving institutional standards of patient care.

As a firm believer in improving public health through better education of healthcare providers, Dr Makin holds a number of academic appointments, including the Director of the 2nd year Endocrinology Curriculum at the Cleveland Clinic Lerner College of Medicine, Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine, Adjunct Assistant Professor at the Ohio Heritage College of Osteopathic Medicine and the past Director of Endocrinology Curriculum at the Cleveland Clinic South Pointe Osteopathic Internal Medicine Residency program. Dr Makin was the Education Fellow at the Cleveland Clinic Education Institute, a highly competitive Fellowship focused on leadership in original, independent research in the field of medical education. A celebrated educator, Dr Makin has won a host of awards for developing the next generation of healthcare professionals, including the Scholarship in Teaching Award in both 2014 and 2016.

Active across a variety of professional organizations, Dr Makin is a board member of the Ohio River Association of Endocrinology), and has served on various national committees such as the AACE National Diversity and Inclusion Committee, AACE Public Impact Committee, the Search committee for the editor- in chief for "Endocrine Practice" as well as "AACE Clinical Case Reports". Recently, as the Director of the EMI grand rounds, Dr Makin has led the transformation of the Endocrinology Grand Rounds through a nationalization initiative called EMI LIVE, which focuses on broadcasting the grand rounds nationally, increasing the outreach, influence and audience tenfold.

A Fellow of the American College of Endocrinology, Dr Makin underwent medical training at the Lady Hardinge Medical College, one of India's top 10 medical colleges. She then pursued an internal medicine residency from John Stroger Hospital of Cook County in Chicago, and completed her endocrinology fellowship from the Cleveland Clinic. Dr Makin is an alumnus of the prestigious Case Western Reserve University FLEX Leadership program, that focuses on developing female physicians for top-tier leadership opportunities.

Dr Janet McGill is Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine in St. Louis, Missouri, and attending physician at Barnes-Jewish Hospital in St. Louis. She directed the fellowship in Endocrinology, Diabetes and Metabolism at Washington University from 2009 - 2016. Dr McGill is nationally and internationally known for her work in clinical and translational research in Type 1 and Type 2 diabetes and diabetes complications. She has been the principal investigator and co-investigator or sub-investigator on over 200 clinical trials in diabetes, hypertension, hyperlipidemia, diabetic nephropathy, diabetic neuropathy and diabetes related devices. In addition to serving on steering and safety committees for international multi-centered clinical trials, she has been the lead investigator on sponsored studies and has served on DSMBs on short and long-term outcome studies. She is the PI of the GRADE and PERL studies at Washington University.

Dr McGill has published over 150 peer-reviewed articles, numerous commentaries and editorials, and 18 chapters, and she has edited two books. She has been on the editorial boards of several journals and has lectured nationally and internationally on diabetes and related topics. She is a member of the board of directors of AACE, and serves on several scientific and planning committees, and is active in the Endocrine Society and ADA.

Dr McGill graduated from the University of Michigan (bachelors), Northern Michigan University (master's) and Michigan State College of Human Medicine. She was an intern, resident and chief resident at William Beaumont Hospital in Royal Oak, Michigan. She completed her fellowship in Endocrinology at Washington University in St. Louis and has been on the faculty since 1987.

Sofia Meier, pediatric nurse practitioner, has had the privilege of working at the Barbara Davis Center (BDC) for 5 years now as a pediatric provider. Sofia received her Master's Degree in Nursing from the University of California, Los Angeles (UCLA).

Sofia manages the continuous glucose monitor program for the Barbara Davis Center including both-diagnostic and personal devices. She is responsible for continuing education on CGM technology (including devices, software, date interpretation and current guidelines) for all BDC staff and providers. Sofia's expertise in CGM data interpretation allows her to maximize patient interactions resulting in leading the clinic in daily patient visits. Her peers also look to her for advice on making insulin adjustments based on CGM data and helping patients achieve glycemic goals.

Sofia travels to 3 BDC affiliated outreach clinics where she shares her expertise in diabetes and current medical devices with children who would not normally have access to this type of care. Sofia also manages the technology education for the staff at her outreach clinics. This involves training all staff members for patient interactions on the latest technology and medical devices on the market.

In addition to Sofia's many contributions to the care of children living with diabetes, one of her greatest accomplishments in the community was the approval of Dexcom for Children with Colorado Medicaid. Sofia spent many tireless hours working with her Dexcom territory business manager to get this approval and as a result, children with CO Medicaid are now able to access Dexcom through a federally funded program (EPSDT). The Barbara Davis Center has now prescribed Dexcom CGM for over 400 children on Medicaid who had no access to it previously.

Elizabeth A Nardacci, MS, FNP-BC, CDE, a family nurse practitioner and diabetes educator, practices at the Capital Region Diabetes and Endocrine Care in Albany, NY which is part of St Peter's Health Partners Medical Associates. She worked at the Goodman Diabetes Service of the Division of Endocrinology at Albany Medical Center as an assistant professor of medicine at Albany Medical College in Albany, New York, and a clinical associate professor at Russell Sage College in Troy, New York.

Ms Nardacci's special interests include diabetes technologies, including professional and personal continuous glucose monitoring (CGM) and insulin pump therapy, chronic kidney disease, and renal transplantation. She has published and delivered presentations to numerous professional groups on these topics. Her practice was featured in a Medical Economics supplement for her professional CGM clinic. She is the primary investigator in the OpT2mise international pivotal trial for use of insulin pump therapy in type 2 diabetes.

She received the Juvenile Diabetes Research Foundation's Inspiration Award. She has served on the editorial board of the ADA journal Clinical Diabetes and serves as an advisor to American Association of Clinical Endocrinologists Task Force on Continuous Glucose Monitoring. She has published articles on diabetes technologies in Diabetes Clinical Technology and Therapeutics, Endocrine Practice, and The Diabetes Educator.

Dr Noureddin has conducted more than 35 investigational, translational, and clinical studies of novel treatments for nonalcoholic steatohepatitis (NASH). He began his hepatology research during his internal medicine residency at the University of Southern California (USC). Following his residency, he moved to the National Institutes of Health (NIH), where he was enrolled in a three-year Hepatology Fellowship at the Liver Diseases Branch of the National Institute of Diabetes and Digestive and Kidney Diseases, which included a combined NIH/Duke University Master of Health Sciences in Clinical Research certification.

After his NIH fellowship, Dr Noureddin finished his Gastroenterology fellowship at the University of California, San Diego, where he focused on NAFLD and NASH and assessing the clinical utility of a new liver-imaging technique, MRI-proton density fat fraction (MRI-PDFF). This scanning methodology is currently considered the new reference standard for the imaging of fatty liver in NAFLD patients.

Dr Noureddin returned to the University of Southern California (USC) and established their fatty liver program to continue research on NAFLD/NASH, while conducting translational research and clinical trials. Subsequently, he joined Cedars-Sinai in 2015 to establish the Cedars-Sinai Fatty Liver Program.

He has an interest in non-invasive testing and biomarkers of the field, especially metabolomics, serum biomarkers, trainset elastography, and magnetic resonance imaging techniques. Dr Noureddin has published in all these areas. He has given invited lectures on NAFLD/NASH at national and international society meetings and serves on several steering committees/advisory boards for industry. He is the Chair of the AASLD NASH Special Interest Education Sub-committee and serves on the editorial board for the journals Clinical Gastroenterology and Hepatology (CGH) and "Gastroenterology."

Jennifer has been a registered dietitian/nutritionist since 2005 and a Certified Diabetes Educator since 2007. She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management. Her unique niche is fluid knowledge on all technology products approved for diabetes care by the FDA. She loves data! She has been a leader in her field in patient care, mentoring, serving as a preceptor, speaking, creating webinars, writing for nutrition and diabetes blogs as well as authoring scientific publications. But what she loves most is taking confusing, complex information and helping people make it usable for them to reach the health goals they set for themselves. When she is not in a clinic or office, she can be found on her bicycle training for a JDRF fundraising ride, paddleboarding on Lake Washington (year around), hiking, traveling the world or just reading a book with a nice glass of wine.

Dr Eric Orzeck earned his medical degree from the University of Virginia Medical Center, Charlottesville, VA, and completed his post-graduate training at the University of Iowa Hospitals, Iowa City, IA.

He completed his first Endocrine Fellowship at the University of Virginia Medical Center, Charlottesville, VA. He completed his second Fellowship at the University of Texas MD Anderson Hospital and Tumor Institute, now the MD Anderson Cancer Center, in Houston, TX.

Dr Orzeck is a Certified Diabetes Educator, and he has been elected to the National Certification Board for Diabetes Educators. He has been published more than 100 times on the subject of Diabetes and other Endocrine diseases.

The Professional Societies and Associations that Dr Orzeck is a member of include the Houston Society of Clinical Endocrinology, where he served as President, and the American Association of Clinical Endocrinologists, where he has been appointed to the Coding Committee, Socioeconomic Committee and is chair of the Nuclear Medicine Certifications Board Committee. Dr Orzeck has also served as President of both the Southeast Texas Chapter of the American Association of Diabetes Educators and the Houston Chapter of the American Diabetes Association. He recently completed a six year term on the Board of Directors of the American Association of Clinical Endocrinologists.

He enjoys his volunteer work with Medical Bridges, an organization which obtains donated medical supplies for shipment to medically underserved areas. He is responsible for repairing and refurbishing electronic items and certifying them to the recipients. In addition, he is a member of the Senior Services department in the city of West University Place, Texas. He provides electrical, plumbing and air conditioning repairs in the homes of those residents certified by the Department as needing assistance.

On the weekends, Dr Orzeck can be found at various venues where he perfects his zydeco dancing.

Susan Owen is a Nurse Practitioner with a specialty in Diabetes at Mercy Health Physician Partners Diabetes and Endo Center in Grand Rapids, MI. She received her BSN at University of Michigan and her MSN from Kent State University in Ohio. Her post master's certificate for Nurse Practitioner is from Grand Valley State University, Grand Rapids. She started her experience in diabetes in Ohio over 30 years ago. She has participated in Diabetes Education, Research and Clinical Practice. Susan has two grown children and currently resides in Grand Rapids, Michigan with her two crazy dogs, Cooper and CJ.

Anne L. Peters, MD, is a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles.

Dr Peters earned her undergraduate degree from Wesleyan University located in Middletown, Connecticut and her medical degree from the Pritzker School of Medicine at the University of Chicago. She performed her internal medicine residency at Stanford University and Harbor UCLA Medical Center (final year) and a fellowship in endocrinology at Cedars-Sinai Medical Center. She was in charge of the clinical diabetes programs at Cedars and then at UCLA before moving to USC.

Dr Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She established the Community Diabetes Initiatives Research Center (CDI) in collaboration with Children's Hospital Los Angeles with funding from the Keck Foundation, JDRF, ADA, NIH, Rose Hills Foundation, California Nutrition Network, TrialNet and the Helmsley Charitable Trust. Dr Peters is a Principal Investigator on two current NIH grants: the NIH Look AHEAD Study and the NIH Vitamin D and Type 2 Diabetes (D2d) Study.

She has been an invited speaker at hundreds of local, national and international medical conferences. Dr Peters has authored four books on diabetes and over 200 articles, reviews and abstracts appearing in peer-reviewed medical journals including JAMA, the New England Journal of Medicine, Annals of Internal Medicine and Diabetes Care. She served on the ABIM Endocrine Board, various ADA and Endocrine Society committees and the EASD/ADA Diabetes Technology Committee. Dr Peters received the ADA Outstanding Physician Clinician Award in 2008 and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved. She is an author of the "ADA/EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes" and the ADA Position Statement on the "Treatment of Type 1 Diabetes Across the Lifespan."

Leslie Pinkerton is a leading pharmacist at Walgreens with more than 19 years of experience. She has successfully managed multiple pharmacies in Chicago, and helped the company launch the program responsible for getting pharmacists licensed to vaccinate, "Flu Shots All Day, Every Day," and the Travel Immunization Program.

She currently is the clinic manager at one of the on-site locations within Northwestern Hospital specializing in diabetes care doubling her store's revenue in one year. Leslie worked with her team to create and manage the first dedicated diabetes clinic for Walgreens at Northwestern Hospital in 2017, which currently services more than 800 patients a month on CGM's and doctors throughout the entire state of Illinois. She is recognized as the expert by her peers and provides insight to patients, doctors and companies expanding into the retail space.

Growing up with a Type 1 diabetic father, Leslie is passionate about sharing her knowledge and experience as well as the future developments within diabetes medical devices and how pharmacists can help their patients and doctors learn about latest products and guidance in the field of diabetes care.

Leslie is a graduate from Mercer University Southern School of Pharmacy in Atlanta, Georgia, and went to undergraduate school at the University of Mississippi.

Leslie grew up in Knoxville, Tennessee and moved to "the big city of Chicago" in 2000.

Leslie is an avid college football fan and an Ole Miss alumni...and has also come to enjoy her Chicago sports teams as well. Leslie enjoys the fine dining Chicago has to offer and her friends that join her on her food adventures.

Dr Plante currently serves as the medical director of the inpatient glycemic team and professor of internal medicine, having nearly 20 years of experience in inpatient and outpatient endocrinology and diabetes. Her current role includes system improvement, aligning the medical center with American Diabetes Association Standards of Care and best practice to improve glycemic benchmarks. She has extensive experience in diabetes technology, including insulin pumps and continuous glucose monitors using pattern recognition to improve time in range. In addition, her expertise includes following current guidelines in using antihyperglycemic agents to reduce cardiovascular outcomes and preventing worsening diabetes-related kidney disease while meeting patient-centered targets with a low risk of hypoglycemia. While her specialty is diabetes, she is well-versed in other endocrine-related disorders, including polycystic ovarian syndrome, thyroid, and menopause.

Dr Plante serves as a co-PI for the T1D Exchange Quality Improvement Collaborative and was recently awarded the Chief of Staff Award in recognition of her expertise and leadership in the glycemic control quality improvement at UC Davis medical center.

Dr Monika Reddy is a Consultant in Diabetes and Endocrinology at Imperial College Healthcare NHS Trust and an Honorary Clinical Senior Lecturer at Imperial College London. Her special interests include structured education and technology in type 1 diabetes management. She completed a PhD on 'Clinical Evaluation of a Closed-loop Insulin Delivery System' at Imperial College London in 2015. Dr Reddy's main research interests lie within the field of Type 1 diabetes and novel technologies including closed-loop insulin delivery systems, minimally invasive glucose sensors and personalised decision support systems.

Dr Stephanie Redmond is a pharmacist currently practicing comprehensive medication management at Ridgeview Medical Center clinics, a practice that she implemented in 2012. She spends most of her time meeting with patients in the endocrinology and primary care clinic, with a focus on diabetes medications as well as emerging diabetes products and technology including insulin pumps and continuous glucose monitors.

Providers send her the most complex and difficult patients because of her ability to motivate and empower them, as well as her expert drug knowledge in the field.

Eric Renard is Chair and Professor of Endocrinology, Diabetes and Metabolism at the medical school of the University of Montpellier, France, where he has held this position since 1999. He also leads the Department of Endocrinology, Diabetes and Nutrition at Lapeyronie University Hospital and is Head of the French National Institute of Health and Medical Research (INSERM) Clinical Research Centre at Montpellier University Hospital, Montpellier, France.

Professor Renard received his medical degree at Montpellier Medical School in 1987, completed a Research Fellowship (Arthur Sachs Scholarship) at Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA in 1992, and received his PhD in Biochemistry & Molecular Biology from the University of Montpellier in 1995.

Professor Renard recently participated in the European FP7 Projects 'DIAdvisor', 'Bringing Artificial Pancreas at home', BIOSID and in the Juvenile Diabetes Research Foundation (JDRF)-sponsored Artificial Pancreas Project. He has also authored more than 220 peer-reviewed papers.

Professor Renard's research interests include intensive insulin therapy aiming at physiological insulin delivery. He devoted a large part of his work on developing insulin pump therapy, investigating the use of intra-peritoneal insulin delivery and implantable pumps and closed-loop insulin delivery systems. Professor Renard currently leads a research team focusing on the 'Determinants and correction of the loss of insulin secretion in diabetes' at the Institute of Functional Genomics, University of Montpellier, France.

Prof Michael Roden is Chair/Professor of Endocrinology and Metabolic Diseases as well as Director of the Department of Endocrinology and Diabetology, Heinrich-Heine University, University Hospital Düsseldorf, and CEO of the German Diabetes Center (DDZ). He was trained at University Vienna and Yale University. His translational research addresses insulin resistance and energy metabolism, specifically using noninvasive technologies, as well as diabetes and its comorbidities, e. g. fatty liver disease. He has published 650+ peer-reviewed papers, received several awards (e. g. Oskar-Minkowski Prize, G. B. Morgagni Gold Medal, Paul-Langerhans Medal) and holds honorary doctorates of the Universities of Athens and Belgrade. Prof Roden was president/congress president of the Central European, the Austrian and the German Diabetes Associations and chairman of the European Federation for the Study of Diabetes (EFSD). From 2017-2022, he was head of the Committee Medicine of the German Council of Science and Humanities, appointed by the President of Germany.

https://en.wikipedia.org/wiki/Michael_Roden

Steven J Russell, MD, PhD, is Assistant Professor of Medicine at Harvard Medical School and an Attending Physician at Massachusetts General Hospital. He completed MD/PhD training at University of Texas Southwestern Medical School and Residency and Fellowship at the Massachusetts General Hospital. He is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr Russell is a the principal clinical investigator of a collaboration between Massachusetts General Hospital and Boston University to develop a wearable bionic pancreas system for automated glycemic management in people with diabetes mellitus. Dr Russell's other projects include evaluation of continuous glucose monitoring technology, methods for automated management of glucose in hospitalized patients, investigations of methods to improve insulin pharmacokinetics, and development of a device for minimally invasive continuous insulin monitoring.

Dr Russell's research is supported by the National Institutes of Health, The Leona M and Harry B Helmsley Charitable Trust, the Banting Foundation, the American Diabetes Association, and the Juvenile Diabetes Research Foundation.

Desmond Schatz, MD is Professor and Interim Chair of Pediatrics, Medical Director of the Diabetes Institute and Director of the Clinical Research Center within the CTSI at the University of Florida, Gainesville. He served as President of Science and Medicine of the American Diabetes Association in 2016. Dr. Schatz has been involved in Type 1 diabetes research since the mid 1980's and has published over 400 manuscripts, the majority related to the prediction, natural history, genetics, immunopathogenesis and prevention of the disease, as well as the management of children and adolescents with Type 1 diabetes. He is the Principal Investigator (PI) on several NIH awards. He is the PI of the University of Florida Clinical Center participating in the NIH-funded TrialNet (a founding member of the DPT-1 in 1994). He is co-PI on a Program Project Grant seeking to understand the immunopathogenesis of Type 1 diabetes, and also serve as PI for the NIH-funded international newborn genetic screening (TEDDY) program in North Central Florida. He is the PI on the NIH-funded Human Islet Research Network (HIRN) Grant evaluating novel markers and mechanisms of beta cell destruction. He is the PI of the University of Florida site participating in the Type 1 Diabetes Exchange. Dr. Schatz has served in numerous capacities (Committees, Study Sections) for the American Diabetes Association, JDRF and NIH. He is the recipient of multiple awards including the Mary Tyler Moore and S Robert Levine JDRF Excellence in Clinical Research Award, the 2009 Cure Award from the American Diabetes Association, the 2010 Public Policy Leadership Award, the prestigious Banting Medal for service from the American Diabetes Association, the ISPAD Prize for achievement (the highest honor of the International Society for Pediatric and Adolescent Diabetes) both in 2016 and, more recently in 2021, the distinguished George Eisenbarth Award from the JDRF for outstanding research advances toward the prevention of Type 1 diabetes. In 2022 he was elected into the prestigious Academy of Science, Engineering and Medicine of Florida (ASEMFL).

Gary Scheiner is owner and Clinical Director of Integrated Diabetes Services, a practice located just outside of Philadelphia specializing in intensive insulin therapy and advanced education for children and adults with type-1 diabetes. An award-winning Certified Diabetes Educator, Masters-level Exercise Physiologist and person with type-1 diabetes since 1985, Gary Scheiner has dedicated his professional life to improving the lives of people with insulin-dependent diabetes. He was named 2014 Diabetes Educator of the year by the American Association of Diabetes Educators.

Gary earned a Bachelor of Arts in Psychology from Washington University in St. Louis and a Master of Science in Exercise Physiology from Benedictine University. He received his diabetes training with the world-renowned Joslin Diabetes Center. Gary serves on the faculty of Children With Diabetes and is an active volunteer for the American Diabetes Association, Juvenile Diabetes Research Foundation, Diabetes Sisters and Setebaid Diabetes Camps. He also serves on the clinical advisory boards for several diabetes device manufacturers and pharmaceutical companies.

Gary has authored six books: You Can Control Diabetes (1997), Think Like A Pancreas (2004, 2012, 2020), The Ultimate Guide to Accurate Carb Counting (2007), Get Control of Your Blood Sugar (2009), Until There's A Cure (2012), Practical CGM (2015) and Diabetes-How To Help (2018), as well as dozens of published articles related to diabetes education for consumer and trade magazines and diabetes websites. He speaks at local, national and international conferences on a multitude of topics in diabetes care. Gary is certified to train on all models of insulin pumps, continuous glucose monitors and hybrid closed loop systems, and has personally used every system that is currently on the market.

A devoted husband and father of four, Gary enjoys exercising (especially basketball, bicycling, running and weight lifting) and cheering on his local Philadelphia sports teams.

Erin Shaal is a PharmD who graduated from Purdue University in 2009. Erin has been working for Albertsons Companies for the past 14 years in various roles including: Pharmacy Operations, Clinical Programs, Learning and Development, Pharmacy Procurement and Specialty Pharmacy. Erin's current role is Director, Specialty Care overseeing the Albertsons Specialty Care Coordination Center, Specialty Pharmacists and Specialty Sales team. Albertsons believes in keeping the patient in the center of all decisions made, which is key in the Specialty at Retail model.

Dr Shah is a Professor of Medicine, Division of Endocrinology & Metabolism and Director of Diabetes Clinical Research at the IU Center for Diabetes and Metabolic diseases at Indiana University. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes.

Dr Shah has been the PI for many clinical trials of diabetes technologies and therapeutics. He has been a part of many landmark research projects that led to FDA approval of newer devices and changed type 1 diabetes management. Moreover, his interest in understanding the effect of diabetes on bone fragility had led to NIH-funded studies investigating effects of long-standing T1D on bone structural and tissue material properties in older adults with type 1 diabetes.

Dr Shah has served in many leadership positions such as steering committee member for T1D Exchange Clinic Registry (2016-2017). He is currently serving as a Chair, Diabetes Technology Interest Group and 83rd/84th Scientific Session Planning Committee member at the American Diabetes Association. He is the recipient of the prestigious AACE Rising Star in Endocrinology Award (2021), ADA Diabetes Technology Interest Group Award (2022), Diabetes Technology Society Leadership Award (2023) and Mary Tyler Moore, and S. Robert Levine, MD Excellence in Clinical Research Award from JDRF (2024).

He serves as the Editor-in-Chief for Clinical Diabetology, Senior Editor for the Endocrine Connections and on the Editorial Board for Diabetes Care and Journal of Diabetes Science and Technology. He is well published with over 170 research publications including original articles, invited reviews, editorials, and book chapters.

Traci Sharkey-Wells is a certified NP and certified Diabetes Educator, currently working for a private endocrine practice in Cleveland, Ohio. She received her undergraduate degree at Indiana University and master's at Kent State University. She has experience in all aspects of endocrinology, however her primary focus has been training patients on insulin infusion therapy as well as continuous glucose monitors. Ms Sharkey-Wells' practice uses pump therapy in both type 1 and type 2 populations. She also does a great deal of inpatient management and rounds at 4 surrounding hospitals. Her practice is also involved in clinical trials for diabetic nephropathy and she serves as a sub PI.

Jennifer Sherr MD, PhD's passion for the care of those with type 1 diabetes (T1D) is quite personal, as she was diagnosed in 1987. From the time of her diagnosis, she was determined to become a pediatric endocrinologist. She completed her undergraduate and medical school training through an accelerated Joint BA/MD program at Rutgers University and the University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School. She then completed both her pediatric residency and pediatric endocrinology fellowship at Yale. While she always wanted to care for those with T1D, her eyes were open to the meaningful impact that clinical research has. She thus embarked on further training through the Yale Graduate School of Arts and Sciences Investigative Medicine Program, a PhD program designed to develop the next generation of physician scientists.

Dr Sherr has been devoted to clinical research since 2006. Her thesis examined the mechanisms responsible for the loss of the glucagon response to hypoglycemia and its relationship to residual beta-cell function. She is an expert in the field of diabetes technology and has worked on trials of continuous glucose monitors and automated insulin delivery systems. She has previously worked on projects with the type 1 diabetes exchange (T1DX) and was selected as the first Junior Pediatric Faculty Member to the T1DX Steering Committee, serving in that role from 2016-2017. Working in an NIH-funded consortium, she is co-leading the Yale site to characterize glycemia across pregnancy. In 2021, she took on the role of lead investigator at Yale for the TrialNet consortium, a group whose purpose is to prevent progression to stage 3 diabetes and preserve residual beta cell function in those who are newly diagnosed with this condition. As a Professor in the department of pediatrics, her goal in both the clinical and research realm is to reduce the burden of living with type 1 diabetes, for both her patients and herself.

John H Sink, II, PA-C, CDE, CLS is a Physician Assistant with The Jones Center for Diabetes and Endocrine Wellness in Macon, Georgia. He has two Bachelor's degrees one from Georgia College and State University and the second from Medical College of Georgia in Physician Assistant Studies. Currently he is completing his Masters in Physician Assistant at Georgia Regents University. He is both a Certified Diabetes Educator and Clinical Lipid Specialist. He practices all aspects of Endocrinology with the majority of practice in diabetes management and thyroid disorders. He has published articles and currently is a sub-investigator in multiple research projects.

Jan Šoupal, MD, PhD graduated from the 1st Faculty of Medicine, Charles University, Prague, Czech Republic, in 2009. He took postgraduate courses in biomedicine at Charles University in Prague and took his Ph.D. in 2017. Currently, he is a deputy head of the Endocrinology Unit at 3rd Department of Internal Medicine, First Faculty of medicine and General University Hospital in Prague. Dr Šoupal is a consultant in internal medicine and a consultant in diabetology and endocrinology. Since 2018 he has been a committee member of the Czech Diabetes Society. In clinical practice, he is focused on diabetes technology with his main interest being Continuous Glucose Monitoring. In his research, he is investigating the effects of glycemic variability on glycemic control and diabetic complications. The results of his research won the Czech Diabetes Association's award for the best original publication in 2013 and 2017. Dr Šoupal is also heavily involved in postgraduate education aimed at improving the treatment of type 1 and type 2 diabetes.

Susan S VanBeuge is an Assistant Professor in Residence at the University of Nevada, Las Vegas School of Nursing. Dr VanBeuge received undergraduate degrees at both Pacific Lutheran University and University of Utah, a Master's degree from UNLV and her doctorate at the University of Utah, College of Nursing. She currently serves as the Master's coordinator and teaches in both the Family Nurse Practitioner and Doctor of Nursing Practice programs. Dr VanBeuge maintains a clinical practice in the sub-specialty of endocrinology and speaks nationally on topics related to this field. She treats patients with general endocrinology diagnoses, as well as many patients with pump therapy and continuous glucose monitoring. Dr VanBeuge has research interests in the areas of interprofessional communication, cancer survivorship, and health promotion. She is a fellow in the American Association of Nurse Practitioners.

Dr Amit C. Vora joined Endocrinology Consultants of East Tennessee in March 2008. He did some of his early schooling in New York where his father taught medicine at New York Medical College. Their family moved back to India and after a few years, he returned to the US to do his training in Internal Medicine at the Cook County Hospital in Chicago where he was bestowed the humanitarian award for two years in a row. This was followed by fellowship training in Endocrinology at Penn State University.

Dr Vora has lectured locally and nationally on diabetes care and is actively involved in the American Diabetes Association as the current President of its volunteer board. Dr Vora is a member of several professional organizations including AACE and the Endocrine Society.

Dr Eugene E. Wright, Jr. holds appointments as Consulting Associate in the Department of Community and Family Medicine and the Department of Medicine of Duke University Medical Center.

Dr Wright has over 40 years of clinical experience as a private practitioner, academic clinician and educator, medical administrator, a rural physician in southeastern North Carolina and a volunteer physician. He currently works with the Charlotte AHEC in Performance Improvement.

Dr Wright serves and has served on several advisory and editorial boards to include Clinical Diabetes, Diabetes Technology and Therapeutics and as a content reviewer for UpToDate. Dr Wright has served on the Planning Committee of the Clinical Conference of the ADA since 2009. He serves as the inaugural chair of the ADA Primary Care Interest Group and as a member of the ADA/AHA Know Diabetes by Heart Science Advisory Group. Dr Wright has published several articles on diabetes diagnosis, treatment and management and has given presentations at national and international meetings on new treatments and technology for diabetes.

Dr Wright has an undergraduate BSE in Electrical Engineering from Princeton University and a medical degree from Duke University School of Medicine. He completed his internship and residency in Internal Medicine at Duke University Hospital in 1981.

Kittie Wyne, MD, PhD, is an endocrinologist specializing in the management of diabetes, lipids and hypertension. She has recently moved to The Ohio State University where she is the Director of the OSU Adult Type 1 Diabetes Program. Dr Wyne earned her medical degree from the Pritzker School of Medicine at the University of Chicago. After serving a residency in internal medicine at Baylor College of Medicine, Houston, Texas, she completed her fellowship in Endocrinology, Diabetes and Metabolism at the University of Texas Southwestern Medical Center, Dallas, Texas. She studied the regulation of the VLDL and HDL receptors and then moved on to the study of fatty acid metabolism and insulin resistance. Dr Wyne is board certified in Endocrinology, Diabetes and Metabolism and in Clinical Lipidology. She is a Fellow of the American College of Endocrinology and of the National Lipid Association.

Her current research interests are related to the role of inflammation and lipid metabolism in the etiology of diabetes. She is specifically interested in studying people at high risk for diabetes, with a goal of developing strategies to prevent diabetes.

Her clinical activities are focused on developing a Center dedicated to adults with type 1 diabetes at The Ohio State University Wexner Medical Center.

Dr Wyne has worked with the Medical Professional Advisory Subcommittee and the Health Professionals Advisory Subcommittee to the Texas Diabetes Council. As a member of these committees, she was involved in revising the current algorithms and writing new algorithms to expand the minimum standards for diabetes care in Texas. Additionally, the committee has been revising the Diabetes Tool Kit, which is an educational resource for health care professionals who work with patients who have diabetes.

She has participated in a number of basic science and clinical research projects. Dr Wyne has published journal articles and abstracts on her work in endocrinology, lipid metabolism, and diabetes treatment. She has presented at the annual meetings of the Endocrine Society, the American Heart Association, the Egyptian Society of Endocrinology and the International Congress of Atherosclerosis. She is a member of several professional medical associations, including the American Diabetes Association, the American Association of Clinical Endocrinology, the American Medical Association, and the American Society of Hypertension. She is a past president of the Texas Chapter of AACE and of the Southwest Lipid Association. She is currently serving on the national board of directors of AACE.

Carol H. Wysham, MD, FACP is a clinical endocrinologist at Multicare/Rockwood Clinic and Clinical Professor of Medicine at University of Washington School of Medicine in Spokane, Washington. Dr Wysham is Past President of the Endocrine Society. She chaired the Professional Practice Committee of the American Diabetes Association in 2011-2012 and served as co-chair and Chair of the Annual Meeting of the Endocrine Society from 2014 – 2016. She has more than 50 publications and over 30 years of clinical research experience, including site principal investigator on the SWITCH, ACCORD, TECOS, EMPA-REG, LEADER, EXCEL, CANVAS, FLOW and SURPASS-CVOT Trials. Dr Wysham is a member of the Endocrine Society and the American Diabetes Association and is a Fellow of the American College of Physicians.

Zobair M. Younossi, MD, MPH is the Chairman of the Global NASH Council, Washington DC and Professor and Chairman of Beatty Liver and Obesity Research, Inova Health System, Falls Church, Virginia. Dr Younossi earned his medical degree from University of Rochester (AOA 1989) with fellowship training in at Scripps Clinic and Research Foundation (1989-1995), while earning his Master of Public Health with multiple honours from San Diego State University (1995). He then worked at Cleveland Clinic Foundation before establishing the Beatty Liver and Obesity Research program and Inova Liver Center. He has served as the Chairman of Department of Medicine, Inova Fairfax (2011-2024), President of Inova Medicine (2019-2024), Chairman of Research for Inova (2005-2022) and Vice Chairman of the Board of Inova Foundation (2011-2024). He currently serves as President of Chronic Liver Disease Foundation (2018-Present). Dr Younossi has pioneered research in MASLD/NAFLD and outcomes research in Liver Disease and has authored over 770 articles, 1090 abstracts and 510 faculty lectures in national and international meetings. He has an H-index of 117 and is listed as the most cited scholars in Liver Disease and NAFLD according to Scholar GPS-2022. Dr Younossi has served on the editorial board of several journals, including Co-Editor of Liver International and Associate Editor of J Hepatology.